Benatti Luca insider trades
Benatti Luca has filed 8 Form 4s with the SEC that we hold, for Quince Therapeutics, Inc. (QNCX) (Director) and ICPT (Director). Across all of them we count 0 purchases worth $0 and 1 sale worth $173.5K reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($173.5K). The largest single trade was a sale of 50,000 shares of Quince Therapeutics, Inc. worth $173.5K, dated 2025-12-26. The first filing on our record is dated 2022-05-27 and the latest 2025-12-29.
Quince Therapeutics, Inc. (QNCX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-12-26 | S, sale reported on Form 4 | 50,000 | $173.5K | 2025-12-29 |
ICPT
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1613842) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms